Oncoheroes Biosciences is joining the Go Gray In May movement

Oncoheroes Biosciences shared on LinkedIn:

“Brain tumors are the leading cause of cancer-related deaths in children. In the US alone, nearly 4,600 children and teenagers are diagnosed with a brain tumor each year.

Despite advancements in medical science, survival rates for certain types of pediatric brain tumors remain stubbornly low, with only around 70% of children surviving five years post-diagnosis. There’s an urgent need to improve treatments for kids and teenagers diagnosed with brain tumors. At Oncoheroes Biosciences, we’re committed to finding better treatments for children diagnosed with cancer, including brain tumors.

This month, we’re joining the Go Gray In May movement to raise awareness about the harsh reality of pediatric brain tumors as we continue our efforts to initiate an international clinical trial that will assess the efficacy of our lead compound, volasertib, in treating brain cancers like medulloblastoma and DIPG.”

Source: Oncoheroes Biosciences/LinkedIn